Article metrics

Download PDFPDF
CP-103 Subcutaneous single-use injection device and intravenous formulations in patients with HER2-positive early breast cancer

 

Online download statistics by month:

Online download statistics by month: February 2014 to January 2024

AbstractFullPdf
Feb 2014201
Mar 2014600
Apr 2014101
May 2014502
Jun 2014800
Jul 20141101
Aug 2014900
Sep 2014300
Oct 2014200
Nov 20141301
Dec 2014600
Jan 20151502
Feb 2015600
Mar 2015303
Apr 2015600
May 2015601
Jun 20151300
Jul 2015300
Aug 2015300
Sep 2015900
Oct 2015200
Nov 2015300
Dec 20151600
Jan 2016900
Feb 2016600
Mar 2016100
Apr 2016301
May 2016300
Jun 2016200
Jul 2016601
Aug 20161001
Sep 20161205
Oct 2016300
Nov 2016700
Dec 2016300
Jan 2017900
Feb 2017300
Mar 2017400
Apr 2017500
May 2017800
Jun 2017300
Jul 2017200
Aug 20171400
Sep 20171601
Oct 20171000
Nov 20171600
Dec 20171200
Jan 2018800
Feb 20181002
Mar 20181200
Apr 20181400
May 2018400
Jun 2018800
Jul 2018800
Aug 20181400
Sep 20181000
Oct 20181001
Nov 20181400
Dec 20181801
Jan 20191800
Feb 20191600
Mar 20192100
Apr 20191600
May 2019200
Jun 2019800
Jul 20192600
Aug 2019400
Sep 20191800
Oct 2019400
Nov 20191300
Dec 20191400
Jan 2020400
Feb 2020600
Mar 20201601
Apr 2020600
May 2020400
Jun 20201801
Jul 20201600
Aug 2020200
Sep 20201400
Oct 20202800
Nov 20201200
Dec 2020600
Jan 2021601
Feb 2021400
Apr 2021400
May 2021001
Oct 2021600
Nov 20211801
Dec 2021200
Feb 2022600
Mar 2022400
Apr 2022800
May 2022800
Jun 20221800
Jul 20221200
Aug 2022200
Sep 2022600
Oct 2022200
Nov 2022600
Dec 20221000
Jan 20231400
Feb 2023800
Mar 2023400
Apr 2023200
May 2023600
Jul 2023200
Sep 2023400
Nov 2023800
Dec 2023600
Jan 2024200
Total918030